Eikon Therapeutics has raised $381 million from its IPO, at the top end of its expectations, in another sign of a pickup in appetite for new biotech listings on the Nasdaq. The South San Francisco ...

Former MSD head of R&D Roger Perlmutter has continued the swift development track for cancer start-up Eikon Therapeutics, filing an IPO to build its already healthy cash position further. Eikon has ...

The key difference between the terms REST versus RESTful is that REST refers to a philosophy about the architecture and design of web services, while the term RESTful refers to any API that properly ...

Supported Releases: These releases have been certified by Bloomberg’s Enterprise Products team for use by Bloomberg customers. Experimental Releases: These releases have not yet been certified for use ...

The Sports Business hub is powered in partnership with leading sports business publishers and voices. The Yahoo Fantasy Sports API gives developers access to real-time fantasy data across Football, ...

Looking for a comprehensive and reliable source of stock market news? Benzinga creates actionable, market-moving stock news content that is all written in-house. Benzinga’s editorial team cuts through ...

BlackRock Large Cap Series Fd.s, Inc.-BlackRock Event Driven Eqy. Fd. 124.23k Feb 28, 2026 0.23% 1,063,443 Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund 111.5k Feb 28, 2026 0.21 ...

Eikon ‍Therapeutics (EIKN), a cancer drug developer led by Merck (MRK) veteran Roger Perlmutter, has filed for its U.S. IPO seeking a valuation of up to $908M with roughly 17.6M shares on offer. The ...

Nasdaq Data Link APIs provide a flexible and efficient method of delivery for real-time exchange data and other financial information. Stock market data is made available through a suite of streaming ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Eikon Therapeutics is a biopharmaceutical company. It engages in the development of medicines for unmet medical needs. The company was founded in 2019 and is headquartered in Millbrae, CA.